Locally activated renin-angiotensin system associated with TGF-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats

Journal of the American Society of Nephrology

Volumn 11, Issue 4, 2000, Pages 616-624

  Kashiwagi, Minoru ^a   Shinozaki, Michiya ^a   Hirakata, Hideki ^a   Tamaki, Kiyoshi ^a   Hirano, Tadashi ^a   Tokumoto, Masanori ^a   Goto, Hiroshige ^a   Okuda, Seiya ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ACTIN; ANGIOTENSIN; FIBRONECTIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034071307     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v114616     Document Type: Article

References (35)

1. Kone BC: Nitric oxide in renal health and disease. Am J Kidney Dis 30: 311-333, 1997
2. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987
3. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988
4. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 48: 20-32, 1995
5. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison BL, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996
6. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272: F561-F578, 1997
7. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992
8. Fujihara CK, Michellazzo SM, de NG, Zatz R: Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 266: F697-F705, 1994
9. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 20: 298-303, 1992
10. Navarro CJ, Maeso R, Rodrigo E, Munoz-Garcia R: Renal and vascular consequences of the chronic nitric oxide synthase inhibition: Effects of antihypertensive drugs. Am J Hypertens 9: 1077-1083, 1996
11. Tojo A, Kobayashi N, Kimura K, Hirata Y, Matsuoka H, Yagi S, Omata M: Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int 49: S138-S140, 1996
12. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993
13. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
14. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86: 453-462, 1990
15. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45: 525-536, 1994
16. Tamaki K, Okuda S, Nakayama M, Yanagida T, Fujishima M: Transforming growth factor-β1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol 7: 2578-2589, 1996
17. Egido J: Vasoactive hormones and renal sclerosis. Kidney Int 49: 578-597, 1996
18. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
19. Puchtler H, Waldrop FS, Meloan SN, Terry MS, Conner HM: Methacarn (methanol-Carnoy) fixation: Practical and theoretical considerations. Histochemie 21: 97-116, 1970
20. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984
21. Bennett WM, Walker RG, Kincaid SP: Renal cortical interstitial volume in mesangial IgA nephropathy: Dissociation from creatinine clearance in serially biopsied patients. Lab Invest 47: 330-335, 1982
22. Heine U, Munoz EF, Flanders KC: Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol 105: 2861-2876, 1987
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
24. Tsuji T, Okada F, Yamaguchi K, Nakamura T: Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA 87: 8835-8839, 1990
25. Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO: Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35: 421-431, 1983
26. Fukuda K, Yanagida T, Okuda S, Tamaki K, Ando T, Fujishima M: Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Int 49: 1320-1329, 1996
27. Cheung HS, Cushman DW: Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochem Biophys Acta 293: 451-463, 1973
28. Iwahana M, Tokumoto M, Makiishi N, Takatori O, Miyazaki N: Fundamental evaluation of no-extraction method of angiotensin I and angiotensin II by radioimmunoassay. J Med Pharm Sci 36: 297-303, 1996
29. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111, 1993
30. Qiu C, Muchant D, Beierwaltes WH, Racusen L, Baylis C: Evolution of chronic nitric oxide inhibition hypertension. Hypertension 31: 21-26, 1998
31. Farhy RD, Carretero OA, Ho KL, Scicli AG: Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72: 1202-1210, 1993
32. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-4171, 1986
33. Lawrence WT, Norton JA, Sporn MB, Gorschboth C, Grotendorst GR: The reversal of an adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg 203: 142-147, 1986
34. Morales TI, Roberts AB: Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures. J Biol Chem 263: 12828-12831, 1988
35. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37: 689-695, 1990